Safety Information

Safety Information

 


Medical Product
Reporting

Reporting Adverse Events to the FDA

Welcome to MedWatch, your Internet gateway for timely safety information on the drugs and other medical products regulated by the U.S. Food and Drug Administration.

A Message About HIPAA Compliance for Reporters to FDA MedWatch New

FDA Logo links to FDA home page
U.S. Food and Drug Administration
  HHS Logo links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program


Join the E-list
Get safety alerts by e-mail

What's New

Oral-B CrossAction Power and PowerMAX Toothbrushes and Refills - Recall issued due to instances where the brush head became loose in the mouth during brushing and was caught in the throat or swallowed.
(Posted 10/29/2004)

Reminyl (galantamine hydrobromide) - Recent reports of medication errors involving confusion between Reminyl and Amaryl.
(Posted 10/26/2004)

Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications - Manufacturers of all antidepressant drugs asked to include in their labeling a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality.
(Posted 10/15/2004)

Remicade (infliximab) - In controlled studies of all TNFα-blocking agents, including Remicade, more cases of lymphoma have been observed among patients receiving the agents than among control group patients.
(Posted 10/13/2004)

 
horizonal rule